The mark consists of the word "argenx" in lowercase in dark gray followed by a V-shaped design, the left segment in dark green and the right segment in green, positioned above a circle in green.
Mark For: ARGENX™ trademark registration is intended to cover the categories of
>The color(s) dark gray, green, dark green is/are claimed as a feature of the mark. The mark consists of the word "argenx" in lowercase in dark gray followed by a V-shaped design, the left segment in dark green and the right segment in green, positioned above a circle in green.
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 97727259 |
Mark Literal Elements | ARGENX |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | NEW APPLICATION PROCESSING 2022-12-24 |
Basis | 44(d) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | No |
44D Filed | Yes |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Domestic Representative | William A. Scofield, Jr., Esq. |
Attorney Name | William A. Scofield, Jr., Esq. |
Attorney Docket Number | 737299 |
2022-12-21 | Application Filed |
2022-12-24 | Location: NEW APPLICATION PROCESSING |
2022-12-24 | Status: Live/Pending |
2022-12-24 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
2022-12-27 | Transaction Date |
Party: | ![]() |
Address | Industriepark Zwijnaarde 7 Zwijnaarde BELGIUM B-9052 |
Legal Entity Type | Besloten Vennootschap (b.v.) |
Legal Entity State | BELGIUM |
![]() | 2022-12-21 | |
![]() | 2022-12-21 | |
![]() | 2023-01-19 |
26.11.27 | Oblongs not used as carriers for words, letters or designs |
260121 | Circles that are totally or partially shaded. |
261127 | Oblongs not used as carriers for words, letters or designs |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceuticals and medical preparations in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
IC 035. US 100 101 102. G & S: Wholesale and retail services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing and patient information services in the field of immunology, diseases of the immune system and antibody therapeutics; provision of customer or patient information on pharmaceutical, medical, healthcare products through an online computer network; administration of patient reimbursement programs
IC 042. US 100 101. G & S: Research and development in the field of immunology, antibody engineering and autoimmune diseases; drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticals, clinical trials, research and development
IC 044. US 100 101. G & S: Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to biopharmaceutical products
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
DM0000 | The mark consists of the word "argenx" in lowercase in dark gray followed by a V-shaped design, the left segment in dark green and the right segment in green, positioned above a circle in green. |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2023-01-19 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-01-18 | |
NEW APPLICATION ENTERED IN TRAM | 2022-12-24 | |
NEW APPLICATION ENTERED | 2022-12-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.